Cytokinetic effects of cisplatin on diverse human head and neck carcinomas in vitro: Dependence on the tumor sensitivity to cisplatin

Journal of Cancer Research and Clinical Oncology

Volumn 122, Issue 10, 1996, Pages 596-602

  Jäckel, Martin C ^a   Tausch Treml, Robert ^b   Köpf Maier, Petra ^c  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^c FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Cell cycle; Cisplatin; Flow cytometry; Head and neck cancer

Indexed keywords

CISPLATIN;

ARTICLE; CELL CYCLE; CONTROLLED STUDY; DRUG SENSITIVITY; FLOW CYTOMETRY; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0029816366     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf01221191     Document Type: Article

References (29)

1. Adelstein DJ, Sharan VM, Earle AS, Shah AC, Valstou C, Haria CD, Damm C, Carter SG, Hines JD (1990) Simultaneous versus sequential combined technique therapy for squamous cell head and neck cancer. Cancer 65: 1685-1691
2. Bergerat J-P, Barlogie B, Böhde W, Johnston DA, Drewinko B (1979) In vitro cytokinetic response of human colon cancer cells to cis-dichlorodiammineplatinum(II). Cancer Res 39: 4356-4363
3. Demarcq C, Bastian G, Remvikos Y (1992) BrdUrd/DNA flow cytometry analysis demonstrated cis-diamminedichloroplatinum (II)-induced multiple cell cycle modifications on human lung carcinoma cells. Cytometry 13: 416-422
4. Eastman A (1986) Reevaluation of interaction of cis-dichloro-(ethylenediammine)platinum(II) with DNA. Biochemistry 25: 3912-3915
5. Evans DL, Dive C (1993) Effects of cisplatin on the induction of apoptosis in proliferating hepatoma cells and nonproliferating immature thymocytes. Cancer Res 53: 2133-2139
6. Fichtinger-Schepman AMJ, Van der Veer JL, Den Hartog JHJ, Lohman PHM, Reedijk J (1985) Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification and quantitation. Biochemistry 24: 707-713
7. Fujikane T, Shimizu T, Tsuji T, Ishida S, Ohsaki Y, Onodera S (1989) Flow cytometric analysis of the kinetic effects of cisplatin on lung cancer cells. Cytometry 10: 788-795
8. Harder HC, Smith RG, Leroy AF (1976) Template primer inactivation by cis- and trans-dichlorodiammineplatinum for human DNA polymerase α, β, and Rauscher murine leukemia virus reverse transcriptase, as a mechanism of cytotoxicity. Cancer Res 36: 3821-3829
9. Jäckel M, Köpf-Maier P (1991) Influence of cisplatin on cell-cycle progression in xenografted human head and neck carcinomas. Cancer Chemother Pharmacol 27: 464-471
10. Jäckel M, Köpf-Maier P (1992) Cell cycle alterations in a xenografted human hypopharynx carcinoma after treatment with carboplatin: influence of acquired resistance to cisplatin. In: Fiebig HH, Berger DP (eds) Immunodeficient mice in oncology. Contrib Oncol 42. Karger, Basel, pp 428-438
11. Jäckel M, Tausch-Treml R, Köpf-Maier P (1994) Effect of acquired cisplatin resistance on the response of a xenografted human hypopharynx carcinoma to concurrent radiochemotherapy with cisplatin. Laryngoscope 104: 329-334
12. Jacobs C, Lyman G, Velez-Garcia E, Sridhar KS, Knight W, Hochster H, Goodnough LT, Mortimer JE, Einhorn LH, Schacter L, Cherng N, Dalton T, Burroughs J, Rozencweig M (1992) A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. J Clin Oncol 10: 257-263
13. Köpf-Maier P, Zimmermann B (1991) Organoid reorganization of human tumors under in vitro conditions. Cell Tissue Res 264: 563-576
14. Köpf-Maier P, Kolon B (1992) An organoid culture assay (OCA) for determining the drug sensitivity of human tumors. Int J Cancer 51: 99-107
15. Lippard SJ, Ushay HM, Merkel HM, Poirier MC (1983) Use of antibodies to probe the stereochemistry of antitumor platinum drug binding to deoxyribonucleic acid. Biochemistry 22: 5165-5168
16. Martin M, Lelièvre G, Gehanno P, Depondt J, Guerrier B, Peytral C (1992) Induction carboplatin (CBDCA) and 5 fluoro-uracile (5 FU) versus no chemotherapy before locoregional treatment for oro and pharyngolaryngeal cancers: preliminary results of a randomized study. Proc ASCO 11: 240
17. Nguyen HN, Sevin B-U, Averette HE, Perras J, Ramos R, Donato D, Ochiai K, Penalver M (1993) Cell cycle perturbations of platinum derivatives on two ovarian cancer cell lines. Cancer Invest 11: 264-275
18. Ormerod MG, Orr RM, Peacock JH (1994) The role of apoptosis in cell killing by cisplatin: a flow cytometric study. Br J Cancer 69: 93-100
19. Perras JP, Ramos R, Sevin B-U (1993) Demonstration of an S phase population of cells without DNA synthesis generated by cisplatin and pentoxifylline. Cytometry 14: 441-448
20. Pinto AL, Lippard SJ (1985) Sequence-dependent termination of in vitro DNA synthesis by cis- and trans-diamminedichloroplatinum(II). Proc Natl Acad Sci USA 82: 4616-4619
21. Sasaki Y, Tamura T, Eguchi K, Shinkai T, Fujiwara Y, Fukuda M, Ohe Y, Bungo M, Horichi M, Niimi S, Minato K, Nakagawa K, Saijo N (1989) Pharmacokinetics of (glycolate-0,0′)-diammine platinum(II), a new platinum derivative, in comparison with cisplatin and carboplatin. Cancer Chemother Pharmacol 23: 243-246
22. Sekiya S, Oosaki T, Andoh S, Suzuki N, Nagao K, Takamizawa H (1988) The isolation and characterization of cisplatin-resistant rat ovarian cancer cells. Eur J Cancer Clin Oncol 24: 851-859
23. Sekiya S, Oosaki T, Andoh S, Suzuki N, Akaboshi M, Takamizawa H (1989) Mechanisms of resistance to cis-diamminedichloroplatinum(II) in a rat ovarian carcinoma cell line. Eur J Cancer Clin Oncol 25: 429-437
24. Sorenson CM, Eastman A (1988a) Mechanism of cis-diamminedichloroplatinum(II)-induced cytotoxicity: role of G2 arrest and DNA double strand breaks. Cancer Res 48: 4484-4488
25. Sorenson CM, Eastman A (1988b) Influence of cis-diamminedichloroplatinum(II) on DNA synthesis and cell cycle progression in excision repair proficient and deficient chinese hamster ovary cells. Cancer Res 48: 6703-6707
26. Sorenson CM, Barry MA, Eastman A (1990) Analysis of events associated with cell cycle arrest at G2 phase and cell death induced by cisplatin. J Natl Cancer Inst 82: 749-755
27. Tannock IF, Browman G (1986) Lack of evidence for a role of chemotherapy in the routine management of locally advanced head and neck cancer. J Clin Oncol 4: 1121-1126
28. Taylor SG, Murthy AK, Caldarelli DD, Showel JL, Kiel K, Griem KL, Mittal BB, Hutchinson JC, Holinger LD, Campanella R, Witt TR, Hoover S (1989) Combined simultaneous cisplatin/fluorouracil chemotherapy and split course radiation in head and neck cancer. J Clin Oncol 7: 846-856
29. Volling P, Staar S, Achterrath W, Müller R-P (1991) Carboplatin plus radiation therapy in head and neck cancer. Semin Oncol 18 [Suppl 2]: 17-22